Search earnings tickers

TMO

2024Q4BMO

Thermo Fisher Scientific Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH

Report 2025-01-30 · Fiscal end 2024-12-31 · Features as of 2025-01-29

← Earnings history

Street

Consensus EPS5.94

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move1.4%

IV front—

P/C full—

P/C front—

Features as of2025-01-29

Run-up

Close—

Ret 5d-1.1%

Ret 10d+2.0%

Ret 20d+8.0%

Ret 30d+8.2%

Print

Actual EPS

6.10Beat

Estimated EPS5.94

Actual revenue

11.4B

Surprise %+2.7%

Beat / missBeat

Beat streak 44

Beat streak 86

Reaction

1-day stock reaction+2.7%

Implied vs actual

Implied 1.4%Actual 3.9%

Gap reaction+3.9%

Day result+6.8%

Next-day upYes

Realized / IV2.75×

Post tape

Post 5d-5.6%

Post 10d-12.2%

Post volume3.3M

Vol ×10d1.64×

Vol ×20d1.71×

Post range3.6%

TMO

Pre-Earnings Data